225 related articles for article (PubMed ID: 15368100)
21. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
[TBL] [Abstract][Full Text] [Related]
22. A novel, de novo germline TP53 mutation in a rare presentation of the Li-Fraumeni syndrome in the maxilla.
Patrikidou A; Bennett J; Abou-Sleiman P; Delhanty JD; Harris M
Oral Oncol; 2002 Jun; 38(4):383-90. PubMed ID: 12076704
[TBL] [Abstract][Full Text] [Related]
23. TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.
Kappel S; Janschek E; Wolf B; Rudas M; Teleky B; Jakesz R; Kandioler D
Breast Cancer Res Treat; 2015 Jun; 151(3):671-8. PubMed ID: 25981898
[TBL] [Abstract][Full Text] [Related]
24. The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds.
Siddiqui R; Onel K; Facio F; Nafa K; Diaz LR; Kauff N; Huang H; Robson M; Ellis N; Offit K
Fam Cancer; 2005; 4(2):177-81. PubMed ID: 15951970
[TBL] [Abstract][Full Text] [Related]
25. Further evidence for pathogenicity of the TP53 tetramerization domain mutation p.Arg342Pro in Li-Fraumeni syndrome.
Etzold A; Schröder JC; Bartsch O; Zechner U; Galetzka D
Fam Cancer; 2015 Mar; 14(1):161-5. PubMed ID: 25226867
[TBL] [Abstract][Full Text] [Related]
26. Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.
Giacomazzi CR; Giacomazzi J; Netto CB; Santos-Silva P; Selistre SG; Maia AL; Oliveira VZ; Camey SA; Goldim JR; Ashton-Prolla P
Rev Assoc Med Bras (1992); 2015; 61(3):282-9. PubMed ID: 26248253
[TBL] [Abstract][Full Text] [Related]
27. Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.
Batalini F; Peacock EG; Stobie L; Robertson A; Garber J; Weitzel JN; Tung NM
Breast Cancer Res; 2019 Sep; 21(1):107. PubMed ID: 31533767
[TBL] [Abstract][Full Text] [Related]
28. Identification of a rare polymorphism in the human TP53 promoter.
Attwooll CL; McGown G; Thorncroft M; Stewart FJ; Birch JM; Varley JM
Cancer Genet Cytogenet; 2002 Jun; 135(2):165-72. PubMed ID: 12127401
[TBL] [Abstract][Full Text] [Related]
29. Nodular Lymphocyte-predominant Hodgkin Lymphoma in a 15-Year-Old Boy With Li-Fraumeni Syndrome Having a Germline TP53 D49H Mutation.
Yamazaki F; Shima H; Osumi T; Narumi S; Kuroda T; Shimada H
J Pediatr Hematol Oncol; 2018 Apr; 40(3):e195-e197. PubMed ID: 28902083
[TBL] [Abstract][Full Text] [Related]
30. Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations.
Shinmura K; Kohno T; Takahashi M; Sasaki A; Ochiai A; Guilford P; Hunter A; Reeve AE; Sugimura H; Yamaguchi N; Yokota J
Carcinogenesis; 1999 Jun; 20(6):1127-31. PubMed ID: 10357799
[TBL] [Abstract][Full Text] [Related]
31. Multiple primary tumors in a family with Li-Fraumeni syndrome with a TP53 germline mutation identified by next-generation sequencing.
Zampiga V; Danesi R; Tedaldi G; Tebaldi M; Cangini I; Pirini F; Pittureri C; Amaducci E; Guidi L; Faedi M; Amadori D; Falcini F; Calistri D
Int J Biol Markers; 2016 Dec; 31(4):e461-e465. PubMed ID: 27516001
[TBL] [Abstract][Full Text] [Related]
32. [Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation].
Landolsi S; Gharbi O; Zrig M; Gribaa M; Njim L; Zakhama A; Abid A; Frébourg T; Ahmed SB
Ann Biol Clin (Paris); 2010; 68(3):346-50. PubMed ID: 20478780
[TBL] [Abstract][Full Text] [Related]
33. Germline TP53 Mutation and Clinical Characteristics of Korean Patients With Li-Fraumeni Syndrome.
Park KJ; Choi HJ; Suh SP; Ki CS; Kim JW
Ann Lab Med; 2016 Sep; 36(5):463-8. PubMed ID: 27374712
[TBL] [Abstract][Full Text] [Related]
34. Three germline mutations in the TP53 gene.
Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ
Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756
[TBL] [Abstract][Full Text] [Related]
35. Analysis of Li-Fraumeni syndrome and Li-Fraumeni-like families for germline mutations in Bcl10.
Stone JG; Eeles RA; Sodha N; Murday V; Sheriden E; Houlston RS
Cancer Lett; 1999 Dec; 147(1-2):181-5. PubMed ID: 10660104
[TBL] [Abstract][Full Text] [Related]
36. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.
Bougeard G; Sesboüé R; Baert-Desurmont S; Vasseur S; Martin C; Tinat J; Brugières L; Chompret A; de Paillerets BB; Stoppa-Lyonnet D; Bonaïti-Pellié C; Frébourg T;
J Med Genet; 2008 Aug; 45(8):535-8. PubMed ID: 18511570
[TBL] [Abstract][Full Text] [Related]
37. Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family.
Evans SC; Mims B; McMasters KM; Foster CJ; deAndrade M; Amos CI; Strong LC; Lozano G
Hum Genet; 1998 Jun; 102(6):681-6. PubMed ID: 9703430
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D
Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788
[TBL] [Abstract][Full Text] [Related]
39. Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families.
Manoukian S; Peissel B; Pensotti V; Barile M; Cortesi L; Stacchiotti S; Terenziani M; Barbera F; Pasquini G; Frigerio S; Pierotti MA; Radice P; Della-Torre G
Eur J Cancer; 2007 Feb; 43(3):601-6. PubMed ID: 17224268
[TBL] [Abstract][Full Text] [Related]
40. Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family.
Güran S; Tunca Y; Imirzalioğlu N
Cancer Genet Cytogenet; 1999 Sep; 113(2):145-51. PubMed ID: 10484981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
